Today’s pharma manufacturers have fast-paced production schedules to respond to the needs of the market. A recent example was the need for large quantities of the Covid-19 vaccine to be produced at speed, which required large-scale production facilities to be set up. At the same time, there is a rising demand in specialized medicines produced in smaller batches, such as cell and gene therapies and monoclonal antibody drugs.
To enable this, manufacturers are shifting from utilizing reusable equipment, often made from stainless steel or glass, toward facilities containing single-use items.
This report, produced in association with Parker Hannifin, explores how single-use items can help solve biopharma’s process challenges, including reducing sterilization times and storage space and ultimately accelerating speed-to-market.
Download this report to find out:
- How single-use technology can help scale up manufacturing
- How to reduce the risk of contamination between production runs
- Why single-use systems have overtaken reusable items in almost all phases of R&D, manufacture, and final fill